阿斯利康一季报:中国区收入18亿美元,ADC药物驱动新增长

21世纪经济报道
29 Apr

21世纪经济报道记者季媛媛上海报道4 月 29 日,阿斯利康发布 2025 年一季度财报,营收 135.88 亿美元,同比增长 10%,其中产品销售额达128.75 亿美元,同比增长9%;研发投入 31.59 亿美元,同比增长 15%。根据财报,今年一季度阿斯利康在美国收入 56.46 亿美元,同比增长10%,占总营收的 42%;中国区收入 18.05 亿美元,同比增长5%,占总营收的 13%。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10